BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6237279)

  • 1. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.
    Foster AC; Vezzani A; French ED; Schwarcz R
    Neurosci Lett; 1984 Aug; 48(3):273-8. PubMed ID: 6237279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurotoxic actions of quinolinic acid in the central nervous system.
    el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
    Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolinate neurotoxicity and glutamatergic structures.
    Keilhoff G; Wolf G; Stastný F; Schmidt W
    Neuroscience; 1990; 34(1):235-42. PubMed ID: 1970138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinate.
    Zhu SG; McGeer EG; McGeer PL
    Brain Res; 1989 Mar; 481(2):356-60. PubMed ID: 2524238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenic acid antagonizes hippocampal quinolinic acid neurotoxicity: behavioral and histological evaluation.
    Lekieffre D; Plotkine M; Allix M; Boulu RG
    Neurosci Lett; 1990 Nov; 120(1):31-3. PubMed ID: 2149878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum.
    Zhu SG; McGeer EG; Singh EA; McGeer PL
    Neurosci Lett; 1988 Dec; 95(1-3):252-6. PubMed ID: 2976129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinic acid neurotoxicity in the nucleus basalis antagonized by kynurenic acid.
    Boegman RJ; el-Defrawy SR; Jhamandas K; Beninger RJ; Ludwin SK
    Neurobiol Aging; 1985; 6(4):331-6. PubMed ID: 2935745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenic Acid Prevents Cytoskeletal Disorganization Induced by Quinolinic Acid in Mixed Cultures of Rat Striatum.
    Pierozan P; Biasibetti-Brendler H; Schmitz F; Ferreira F; Pessoa-Pureur R; Wyse ATS
    Mol Neurobiol; 2018 Jun; 55(6):5111-5124. PubMed ID: 28840509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-Induced Toxicity in Rat Striatal Slices.
    Ferreira FS; Biasibetti-Brendler H; Pierozan P; Schmitz F; Bertó CG; Prezzi CA; Manfredini V; Wyse ATS
    Mol Neurobiol; 2018 Nov; 55(11):8538-8549. PubMed ID: 29564809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity of tryptophan metabolites.
    Boegman RJ; Jhamandas K; Beninger RJ
    Ann N Y Acad Sci; 1990; 585():261-73. PubMed ID: 2141454
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of antagonists of exciting amino acids on the neuro-destructive effect of quinolinic acid in vitro in comparison with their anticonvulsive action in situ].
    Khaspekov LG; Lapin IP; Ryzhov IV; Viktorov IV
    Biull Eksp Biol Med; 1989 Aug; 108(8):190-3. PubMed ID: 2529920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrastriatal Quinolinic Acid Administration Impairs Redox Homeostasis and Induces Inflammatory Changes: Prevention by Kynurenic Acid.
    Ferreira FS; Schmitz F; Marques EP; Siebert C; Wyse ATS
    Neurotox Res; 2020 Jun; 38(1):50-58. PubMed ID: 32219734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.
    Jhamandas K; Boegman RJ; Beninger RJ; Bialik M
    Brain Res; 1990 Oct; 529(1-2):185-91. PubMed ID: 2149296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
    Engber TM; Chase TN
    Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxic effects of endogenous materials: quinolinic acid, L-pyroglutamic acid, and thyroid releasing hormone (TRH).
    McGeer EG; Singh E
    Exp Neurol; 1984 Nov; 86(2):410-3. PubMed ID: 6436049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat.
    Lombardi G; Zanoni R; Moroni F
    Eur J Pharmacol; 1989 Dec; 174(1):123-5. PubMed ID: 2612575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The organotypic tissue culture model of corticostriatal system used for examining amino acid neurotoxicity and its antagonism: studies on kainic acid, quinolinic acid and (-) 2-amino-7-phosphonoheptanoic acid.
    Whetsell WO; Schwarcz R
    J Neural Transm Suppl; 1983; 19():53-63. PubMed ID: 6321650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenic acid-induced protection of neurochemical and behavioural deficits produced by quinolinic acid injections into the nucleus basalis of rats.
    Beninger RJ; Jhamandas K; Boegman RJ; el-Defrawy SR
    Neurosci Lett; 1986 Aug; 68(3):317-21. PubMed ID: 2944036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of quinolinate in the rat nucleus basalis magnocellularis.
    Boegman RJ; Metcalf R; Riopelle RJ; Ludwin SK
    Brain Res; 1987 Aug; 417(2):315-20. PubMed ID: 2958107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid protects against the neurochemical and behavioral effects of unilateral quinolinic acid injections into the nucleus basalis of rats.
    Wirsching BA; Beninger RJ; Jhamandas K; Boegman RJ; Bialik M
    Behav Neurosci; 1989 Feb; 103(1):90-7. PubMed ID: 2522306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.